- Investing Ideas
- U.S. Pharmaceuticals & Biotech Leverage Leaders
U.S. Pharmaceuticals & Biotech Leverage Leaders
Results
78
78 companies
Agios Pharmaceuticals
Market Cap: US$2.0b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$34.16
7D
16.0%
1Y
-0.7%
Ocular Therapeutix
Market Cap: US$2.1b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$9.43
7D
5.5%
1Y
16.0%
Dyne Therapeutics
Market Cap: US$3.3b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$19.80
7D
8.9%
1Y
91.9%
Nuvalent
Market Cap: US$9.8b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$123.43
7D
0.1%
1Y
64.6%
Veradermics
Market Cap: US$3.9b
A clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.
MANE
US$93.87
7D
-2.3%
1Y
n/a
Crinetics Pharmaceuticals
Market Cap: US$3.8b
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRNX
US$35.87
7D
4.1%
1Y
18.9%